A multicenter, randomized, controlled, single‐blind comparison phase III study to determine the efficacy and safety of gadobutrol 1.0 M versus gadopentetate dimeglumine following single injection in patients referred for contrast‐enhanced MRI of the body regions or extremities

Publisher: John Wiley & Sons Inc

E-ISSN: 1522-2586|41|2|404-413

ISSN: 1053-1807

Source: JOURNAL OF MAGNETIC RESONANCE IMAGING, Vol.41, Iss.2, 2015-02, pp. : 404-413

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content